GSA CAPITAL PARTNERS LLP - INTEC PHARMA LTD JERUSALEM ownership

Back to all holdings Add to watchlist

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 26 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2020$55,000
+400.0%
218,211
+855.6%
0.01%
+800.0%
Q4 2019$11,000
+10.0%
22,834
+64.2%
0.00%0.0%
Q3 2019$10,000–13,908–0.00%–
 Download
Other shareholders

There were no reported owners of INTEC PHARMA LTD JERUSALEM in Q3 2020.

NameSharesValueWeighting ↓
View complete list of INTEC PHARMA LTD JERUSALEM shareholders